Abciximab Completed Phase 4 Trials for Myocardial Infarction Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00133250Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)
NCT00354406Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty
NCT01757457Anti-inflammatory Effects of Intracoronary and Intravenous Abciximab Administration During Primary Percutaneous Coronary Intervention